Severe pediatric cardiac decompensation has a mortality risk of 50-65% and is the leading cause of death in children. Heart transplantation is the current standard of care for end-stage pediatric ...
HeartWare Ltd., an Australian company with an American office in Framingham, announced the first U.S. patient has received the company’s miniaturized blood pump, which is the first of a clinical trial ...